Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.01%64.6M | 20.50%67.97M | -4.62%64.1M | -5.93%270.51M | 10.03%82.29M | 1.98%64.61M | -15.51%56.41M | -18.71%67.2M | 18.29%287.57M | -16.46%74.79M |
| Cost of revenue | 2.59%48.04M | 16.89%50.28M | -9.23%49.57M | -5.47%207.91M | 4.59%63.46M | 1.44%46.83M | -11.85%43.01M | -16.50%54.61M | 24.62%219.93M | -2.59%60.67M |
| Gross profit | -6.86%16.57M | 32.08%17.69M | 15.41%14.52M | -7.45%62.6M | 33.41%18.83M | 3.42%17.79M | -25.43%13.39M | -27.06%12.59M | 1.53%67.63M | -48.18%14.11M |
| Operating expense | -76.35%8.48M | -13.74%21.07M | 9.92%20.43M | -4.09%127.22M | -36.13%47.83M | 86.61%35.84M | 21.77%24.42M | -3.31%18.58M | 29.30%132.65M | 47.26%74.89M |
| Selling and administrative expenses | ---- | ---- | ---- | 2.82%55.42M | ---- | ---- | ---- | ---- | 0.00%53.9M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -30.71%4.02M | ---- | ---- | ---- | ---- | 4.69%5.8M | ---- |
| -General and administrative expense | ---- | ---- | ---- | 6.86%51.4M | ---- | ---- | ---- | ---- | -0.54%48.1M | ---- |
| Other operating expenses | -41.46%21.4M | -18.18%22.3M | -3.10%21.06M | -35.18%85.48M | -54.49%55.6M | 63.27%36.56M | 29.33%27.25M | 5.30%21.74M | 139.04%131.88M | 5,416.84%122.18M |
| Total other operating income | 1,707.41%12.92M | -56.46%1.23M | -79.81%637K | -74.26%13.68M | -83.55%7.78M | -77.54%715K | 178.19%2.83M | 121.56%3.16M | 719.92%53.13M | 6,239.81%47.3M |
| Operating profit | 144.80%8.09M | 69.39%-3.38M | 1.58%-5.9M | 0.60%-64.63M | 52.29%-29M | -799.15%-18.06M | -426.65%-11.03M | -205.19%-6M | -80.74%-65.02M | -157.37%-60.77M |
| Net non-operating interest income (expenses) | 28.51%-1.52M | 21.90%-1.68M | 14.51%-1.74M | 19.59%-8.18M | 58.82%-1.87M | -31.15%-2.12M | -8.29%-2.16M | -11.76%-2.03M | -88.23%-10.17M | -464.52%-4.53M |
| Non-operating interest income | -66.97%144K | -73.18%166K | -76.44%176K | 89.74%2.37M | 0.35%566K | 181.29%436K | 17.90%619K | 249.07%747K | -4.88%1.25M | --564K |
| Non-operating interest expense | -35.07%1.66M | -33.35%1.85M | -31.15%1.91M | -7.64%10.54M | -52.27%2.43M | 44.28%2.56M | 10.30%2.77M | 36.74%2.78M | 70.03%11.42M | 7,284.06%5.1M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -14.29%6K | 10.00%22K | -36.36%7K | 200.00%38K | 0 | 450.00%7K | -20.00%20K | 1,200.00%11K | -133.63%-38K | -1,100.00%-60K |
| Special income (charges) | 134.14%551K | -1.61M | ||||||||
| Less:Write off | ---- | ---- | ---- | -134.14%-551K | ---- | ---- | ---- | ---- | --1.61M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 132.61%6.58M | 61.73%-5.04M | 4.81%-7.63M | 6.01%-72.21M | 52.78%-30.86M | -455.95%-20.17M | -224.29%-13.16M | -111.86%-8.02M | -86.22%-76.84M | -192.27%-65.36M |
| Income tax | -30.40%506K | 2,789.29%753K | 2,131.03%589K | -9.82%3.42M | 6.10%2.75M | 8.02%727K | -107.67%-28K | -117.90%-29K | 19.52%3.79M | 143.42%2.59M |
| Net income | 129.06%6.07M | 55.92%-5.79M | -2.90%-8.22M | 6.19%-75.63M | 50.54%-33.61M | -385.86%-20.9M | -196.90%-13.14M | -102.43%-7.99M | -81.46%-80.63M | -190.05%-67.95M |
| Net income continuous operations | 129.06%6.07M | 55.92%-5.79M | -2.90%-8.22M | 6.19%-75.63M | 50.54%-33.61M | -385.86%-20.9M | -196.90%-13.14M | -102.43%-7.99M | -81.46%-80.63M | -190.05%-67.95M |
| Noncontrolling interests | 67.87%-2.96M | 87.20%-771K | -802.00%-902K | 45.97%-16.9M | 94.60%-1.57M | -456.46%-9.22M | -3,173.91%-6.02M | 78.07%-100K | -242.30%-31.29M | -293.19%-28.99M |
| Net income attributable to the company | 177.32%9.03M | 29.42%-5.02M | 7.22%-7.32M | -19.03%-58.73M | 17.76%-32.05M | -341.66%-11.68M | -67.71%-7.11M | -126.01%-7.89M | -39.81%-49.34M | -142.68%-38.96M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 177.32%9.03M | 29.42%-5.02M | 7.22%-7.32M | -19.03%-58.73M | 17.76%-32.05M | -341.66%-11.68M | -67.71%-7.11M | -126.01%-7.89M | -39.81%-49.34M | -142.68%-38.96M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 178.26%0.0036 | 28.57%-0.002 | 6.45%-0.0029 | -18.97%-0.0232 | 17.53%-0.0127 | -360.00%-0.0046 | -64.71%-0.0028 | -121.43%-0.0031 | 33.67%-0.0195 | -29.58%-0.0154 |
| Diluted earnings per share | 178.26%0.0036 | 28.57%-0.002 | 6.45%-0.0029 | -18.97%-0.0232 | 17.53%-0.0127 | -360.00%-0.0046 | -64.71%-0.0028 | -121.43%-0.0031 | 33.67%-0.0195 | -29.58%-0.0154 |
| Dividend per share | 0.00%0.0005 | 0 | 0 | -50.00%0.0005 | 0 | -50.00%0.0005 | 0 | 0 | -21.20%0.001 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.